Target intelligence / Profile preview

Ocular Surface and Tear Film Components

Molecular classification
Other (Composite biological structure involving proteins, lipids, mucins, electrolytes, and cellular tissues such as corneal epithelium, conjunctiva, meibomian glands, and lacrimal glands)
01

Overview

The **ocular surface and tear film components** together form a complex anatomical and functional unit, including the corneal and conjunctival epithelium, meibomian and lacrimal glands, and the tears themselves[1][4]. The tear film is composed of an outer lipid layer (from meibomian glands), a central aqueous layer (from lacrimal glands), and an inner mucin layer (from conjunctival goblet cells), each conferring specific protective, lubricative, immune, and optical properties[1][2][3][5][6]. The integrity and stability of this unit are essential for vision, ocular comfort, and defense against pathogens, with dysfunction resulting in diseases such as dry eye, inflammation, and increased risk for infection[2][4][5][6].

Other names
Ocular surface unittear filmlacrimal functional unitpreocular tear film
02

Mechanism of action

Immunomodulation (e.g., cyclosporine inhibits inflammatory cytokine production in lacrimal glands and ocular surface) Lubrication/replacement of deficient tear components (artificial tears supplement aqueous/mucin/lipid) Lymphocyte function antagonist (lifitegrast blocks specific inflammation pathways in dry eye)

03

Biological functions

Lubrication of the ocular surface and eyelidAntimicrobial defenseMaintaining a smooth optical surface for refractionEpithelial health and wound healingPrevention of evaporation and tear stabilizationImmune protection
04

Disease associations

Dry eye disease (tear film instability and deficiency)Ocular surface inflammationInfection (reduced tear film leaves eye vulnerable)Neuropathic pain due to functional denervation (secondary to other disease)
05

Safety considerations

Limited penetration or efficacy of drugs due to tear film instabilityPotential for irritation or allergy to components in replacement or therapeutic agentsPreservation of normal tear film composition is essential to avoid further surface damage
06

Interacting drugs

Cyclosporine

3 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT; measure of tear film stability)Schirmer test (tear production)Ocular surface staining (e.g., fluorescein, lissamine green for detecting epithelial damage)

Beyond the preview

Go deeper on Ocular Surface and Tear Film Components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular Surface and Tear Film Components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call